Deutsche Bank’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$560K Sell
50,765
-144,516
-74% -$2.23M ﹤0.01% 2516
2025
Q4
$3.98M Buy
195,281
+172,022
+740% +$3.02M ﹤0.01% 1416
2025
Q3
$368K Sell
23,259
-188,378
-89% -$2.78M ﹤0.01% 2710
2025
Q2
$2.83M Buy
211,637
+188,675
+822% +$2.55M ﹤0.01% 1511
2025
Q1
$234K Sell
22,962
-3,995
-15% -$46.4K ﹤0.01% 2884
2024
Q4
$427K Buy
26,957
+8,447
+46% +$439K ﹤0.01% 2696
2024
Q3
$1.07M Sell
18,510
-105,603
-85% -$5.22M ﹤0.01% 2075
2024
Q2
$5.67M Buy
124,113
+41
+0% +$2.2K ﹤0.01% 1201
2024
Q1
$8.21M Sell
124,072
-234,204
-65% -$13.9M ﹤0.01% 1094
2023
Q4
$14.2M Buy
358,276
+345,704
+2,750% +$10.8M 0.01% 888
2023
Q3
$401K Sell
12,572
-70,319
-85% -$2.63M ﹤0.01% 2309
2023
Q2
$3.33M Sell
82,891
-4,505
-5% -$197K ﹤0.01% 1399
2023
Q1
$3.73M Buy
87,396
+75,946
+663% +$3.84M ﹤0.01% 1358
2022
Q4
$550K Buy
11,450
+3,406
+42% +$159K ﹤0.01% 2396
2022
Q3
$303K Sell
8,044
-2,231
-22% -$77.3K ﹤0.01% 2684
2022
Q2
$285K Buy
10,275
+135
+1% +$5.92K ﹤0.01% 2951
2022
Q1
$552K Sell
10,140
-1,006
-9% -$51.6K ﹤0.01% 2688
2021
Q4
$652K Buy
11,146
+369
+3% +$18.4K ﹤0.01% 2675
2021
Q3
$427K Sell
10,777
-287
-3% -$10.2K ﹤0.01% 3150
2021
Q2
$469K Buy
11,064
+1,412
+15% +$76.5K ﹤0.01% 3264
2021
Q1
$593K Sell
9,652
-792
-8% -$50.2K ﹤0.01% 2997
2020
Q4
$736K Buy
10,444
+6,592
+171% +$415K ﹤0.01% 2655
2020
Q3
$149K Buy
3,852
+336
+10% +$13.3K ﹤0.01% 3366
2020
Q2
$132K Buy
+3,516
New +$108K ﹤0.01% 3322

Other funds holding KROS